Co-Authors
This is a "connection" page, showing publications co-authored by Yitshak Kreiss and Gili Regev-Yochay.
Connection Strength
1.785
-
Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel. Lancet Reg Health Eur. 2021 Aug; 7:100150.
Score: 0.955
-
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N Engl J Med. 2021 10 14; 385(16):1474-1484.
Score: 0.240
-
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lancet Respir Med. 2021 09; 9(9):999-1009.
Score: 0.239
-
Establishing a COVID-19 treatment centre in Israel at the initial stage of the outbreak: challenges, responses and lessons learned. Emerg Med J. 2021 May; 38(5):373-378.
Score: 0.234
-
COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply. Lancet. 2021 06 12; 397(10291):2249-2250.
Score: 0.059
-
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Lancet. 2021 03 06; 397(10277):875-877.
Score: 0.058